Blog

Defining Progression of NSCLC on Immunotherapy – Targeted Oncology


Targeted Oncology

Defining Progression of NSCLC on Immunotherapy
Targeted Oncology
Defining Progression of NSCLC on Immunotherapy. Corey Langer, MD. Published Online:Apr 18, 2017. In this case-based interview, Corey Langer, MD, discusses the treatment of a patient with locally advanced squamous non-small cell lung cancer and …

and more »

2017-04-18 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.